Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...

A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...

A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...

Lenacapavir prevents infection and treats HIV, not a 'cure' HIV is the virus that causes AIDS − a disease in which the immune system is damaged to the point that its ability to resist infection ...

How does lenacapavir compare to other HIV prevention drugs? Pre-exposure prophylaxis, or PrEP, medications are sold as a daily pill under brand names Truvada and Descovy, as well as generic versions.

Another study, opens new tab published in NEJM on Nov. 27 found lenacapavir reduced HIV infections by 96% compared to background HIV incidence among a broad and geographically diverse range of ...